13F

Stock

Prelude Therapeutics Inc

PRLD · held by 5 managers

Reported value

$434.6K

Holders

5

+0 new · −0 exited

Holders’ est. mark

$5.43K

Price effect on 2 books still in the name

Largest holder

$409.3K

MORGAN STANLEY

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
MORGAN STANLEY284.2K$409.3KHeld
BANK OF AMERICA CORP /DE/8.85K$12.7KHeld
BARCLAYS PLC8.71K$12.5K$5.42KAdded$5.58K
IFP Advisors, Inc18$26Held
Essential Partners LLC17$24$10Cut−$46

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.